# Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function

> **NCT02633540** · PHASE2 · TERMINATED · sponsor: **Fox Chase Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Laryngeal Neoplasms

## Interventions

- **RADIATION:** IMRT Radiation

## Key facts

- **NCT ID:** NCT02633540
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11-16
- **Primary completion:** 2017-10
- **Final completion:** 2018-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633540, "Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02633540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*